Setting

Asia Pacific Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Published: 26 Oct 2020 | Report Code: 10247755 | Pages: 129

Asia Pacific clinical nutrition market will grow by 8.27% annually with a total addressable market cap of $180.67 billion over 2020-2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic. Highlighted with 35 tables and 69 figures, this 129-page report “Asia Pacific Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country. Based on Substrate, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Carbohydrates • Lipids • Proteins & Amino Acids • Water & Electrolyte • Dietary Fiber • Antioxidants • Other Substrates Based on Administration Route, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. Oral or Enteral Administration • Oral Nutrition Supplements • Tube Feeding Parenteral Administration • Supplemental Parenteral Nutrition • Total Parenteral Nutrition • All-in-One System • Multiple Bottle System Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Infant • Children • Adult • Geriatrics Based on Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Malnutrition • Metabolic Disorders • Gastrointestinal Disorders • Cancer • Neurology • Renal Diseases • Respiratory Diseases • Other Therapeutic Areas Based on Healthcare Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Hospitals • Long-term Care Facilities (LTC) • Homecare • Inpatient Rehabilitation Facilities • Other Healthcare Settings Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Institutional Sales • Supermarkets & Hypermarkets • Pharmacies • Drug Stores • Online Channels • Other Distribution Channels Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each country, detailed analysis and data for annual revenue are available for 2019-2026. The breakdown of key national markets by Administration Route, End User, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific clinical nutrition market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Nutrition B Braun Melsungen Ag BASF SE Baxter International Inc. Claris Lifesciences Ltd. Fresenius Kabi Ag Lonza Group AG Nestle Health Science Nutricia Ltd Perrigo Company Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	29
2.4 Emerging Opportunities and Market Trends	32
2.5 Porter’s Fiver Forces Analysis	36
3 Segmentation of Asia Pacific Market by Substrate	40
3.1 Market Overview by Substrate	40
3.2 Carbohydrates	42
3.3 Lipids	43
3.4 Proteins & Amino Acids	44
3.5 Water & Electrolyte	45
3.6 Dietary Fiber	46
3.7 Antioxidants	47
3.8 Other Substrates	48
4 Segmentation of Asia Pacific Market by Administration Route	49
4.1 Market Overview by Administration Route	49
4.2 Oral or Enteral Administration	51
4.2.1 Oral Nutrition Supplements	53
4.2.2 Tube Feeding	54
4.3 Parenteral Administration	55
4.3.1 Supplemental Parenteral Nutrition	57
4.3.2 Total Parenteral Nutrition	58
4.3.3 All-in-One System	59
4.3.4 Multiple Bottle System	60
5 Segmentation of Asia Pacific Market by End User	61
5.1 Market Overview by End User	61
5.2 Infant	63
5.3 Children	64
5.4 Adult	65
5.5 Geriatrics	66
6 Segmentation of Asia Pacific Market by Therapeutic Area	67
6.1 Market Overview by Therapeutic Area	67
6.2 Malnutrition	69
6.3 Metabolic Disorders	70
6.4 Gastrointestinal Disorders	71
6.5 Cancer	72
6.6 Neurology	73
6.7 Renal Diseases	74
6.8 Respiratory Diseases	75
6.9 Other Therapeutic Areas	76
7 Segmentation of Asia Pacific Market by Healthcare Setting	77
7.1 Market Overview by Healthcare Setting	77
7.2 Hospitals	79
7.3 Long-term Care Facilities (LTC)	80
7.4 Homecare	81
7.5 Inpatient Rehabilitation Facilities	82
7.6 Other Healthcare Settings	83
8 Segmentation of Asia Pacific Market by Distribution Channel	84
8.1 Market Overview by Distribution Channel	84
8.2 Institutional Sales	86
8.3 Supermarkets & Hypermarkets	87
8.4 Pharmacies	88
8.5 Drug Stores	89
8.6 Online Channels	90
8.7 Other Distribution Channels	91
9 Asia-Pacific Market 2019-2026 by Country	92
9.1 Overview of Asia-Pacific Market	92
9.2 China	95
9.3 Japan	97
9.4 India	100
9.5 Australia	102
9.6 South Korea	104
9.7 Rest of APAC Region	106
10 Competitive Landscape	108
10.1 Overview of Key Vendors	108
10.2 New Product Launch, Partnership, Investment, and M&A	111
10.3 Company Profiles	112
Abbott Nutrition	112
B Braun Melsungen Ag	114
BASF SE	115
Baxter International Inc.	116
Claris Lifesciences Ltd.	117
Fresenius Kabi Ag	118
Lonza Group AG	119
Nestle Health Science	120
Nutricia Ltd	121
Perrigo Company Plc	122
11 Investing in Asia Pacific Market: Risk Assessment and Management	123
11.1 Risk Evaluation of Asia Pacific Market	123
11.2 Critical Success Factors (CSFs)	126
Related Reports and Products	129
List Of Tables

Table 1.  Snapshot of Asia Pacific Clinical Nutrition Market, 2019-2026	18
Table 2. Growth Rate of World Real GDP, 2017-2021	22
Table 3.  Main Product Trends and Market Opportunities in Asia Pacific Clinical Nutrition Market	32
Table 4. Asia Pacific Clinical Nutrition Market by Substrate, 2015-2026, $ mn	40
Table 5. Asia Pacific Clinical Nutrition Market by Administration Route, 2015-2026, $ mn	49
Table 6. Asia Pacific Clinical Nutrition Market: Oral or Enteral Administration by Type, 2015-2026, $ mn	52
Table 7. Asia Pacific Clinical Nutrition Market: Parenteral Administration by Type, 2015-2026, $ mn	56
Table 8. Asia Pacific Clinical Nutrition Market by End User, 2015-2026, $ mn	61
Table 9. Asia Pacific Clinical Nutrition Market by Therapeutic Area, 2015-2026, $ mn	67
Table 10. Asia Pacific Clinical Nutrition Market by Healthcare Setting, 2015-2026, $ mn	77
Table 11. Asia Pacific Clinical Nutrition Market by Distribution Channel, 2015-2026, $ mn	84
Table 12. APAC Clinical Nutrition Market by Country, 2015-2026, $ mn	93
Table 13. China Clinical Nutrition Market by Administration Route, 2015-2026, $ mn	96
Table 14. China Clinical Nutrition Market by End User, 2015-2026, $ mn	96
Table 15. China Clinical Nutrition Market by Therapeutic Area, 2015-2026, $ mn	96
Table 16. Japan Clinical Nutrition Market by Administration Route, 2015-2026, $ mn	99
Table 17. Japan Clinical Nutrition Market by End User, 2015-2026, $ mn	99
Table 18. Japan Clinical Nutrition Market by Therapeutic Area, 2015-2026, $ mn	99
Table 19. India Clinical Nutrition Market by Administration Route, 2015-2026, $ mn	101
Table 20. India Clinical Nutrition Market by End User, 2015-2026, $ mn	101
Table 21. India Clinical Nutrition Market by Therapeutic Area, 2015-2026, $ mn	101
Table 22. Australia Clinical Nutrition Market by Administration Route, 2015-2026, $ mn	103
Table 23. Australia Clinical Nutrition Market by End User, 2015-2026, $ mn	103
Table 24. Australia Clinical Nutrition Market by Therapeutic Area, 2015-2026, $ mn	103
Table 25. South Korea Clinical Nutrition Market by Administration Route, 2015-2026, $ mn	105
Table 26. South Korea Clinical Nutrition Market by End User, 2015-2026, $ mn	105
Table 27. South Korea Clinical Nutrition Market by Therapeutic Area, 2015-2026, $ mn	105
Table 28. Clinical Nutrition Market in Rest of APAC by Country, 2015-2026, $ mn	107
Table 29. Abbott Nutrition: Company Snapshot	112
Table 30. Abbott Nutrition: Business Segmentation	112
Table 31. Abbott Nutrition: Product Portfolio	113
Table 32. Abbott Nutrition: Revenue, 2016-2018, $ mn	113
Table 33. Abbott Nutrition: Recent Developments	113
Table 34.  Risk Evaluation for Investing in Asia Pacific Market, 2019-2026	124
Table 35. Critical Success Factors and Key Takeaways	127
List Of Figures

Figure 1. Research Method Flow Chart	11
Figure 2. Breakdown of Primary Research	13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026	17
Figure 5. Asia Pacific Clinical Nutrition Market, 2019-2026, $ mn	20
Figure 6. Impact of COVID-19 on Business	24
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Clinical Nutrition Market	26
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Clinical Nutrition Market	29
Figure 9. Investment Opportunity Analysis	33
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Clinical Nutrition Market	36
Figure 11. Breakdown of Asia Pacific Clinical Nutrition Market by Substrate, 2019-2026, % of Revenue	41
Figure 12. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Substrate, Value ($ mn) and Share (%)	41
Figure 13. Asia Pacific Clinical Nutrition Market: Carbohydrates, 2015-2026, $ mn	42
Figure 14. Asia Pacific Clinical Nutrition Market: Lipids, 2015-2026, $ mn	43
Figure 15. Asia Pacific Clinical Nutrition Market: Proteins & Amino Acids, 2015-2026, $ mn	44
Figure 16. Asia Pacific Clinical Nutrition Market: Water & Electrolyte, 2015-2026, $ mn	45
Figure 17. Asia Pacific Clinical Nutrition Market: Dietary Fiber, 2015-2026, $ mn	46
Figure 18. Asia Pacific Clinical Nutrition Market: Antioxidants, 2015-2026, $ mn	47
Figure 19. Asia Pacific Clinical Nutrition Market: Other Substrates, 2015-2026, $ mn	48
Figure 20. Breakdown of Asia Pacific Clinical Nutrition Market by Administration Route, 2019-2026, % of Revenue	49
Figure 21. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Administration Route, Value ($ mn) and Share (%)	50
Figure 22. Asia Pacific Clinical Nutrition Market: Oral or Enteral Administration, 2015-2026, $ mn	51
Figure 23. Asia Pacific Clinical Nutrition Market: Oral Nutrition Supplements, 2015-2026, $ mn	53
Figure 24. Asia Pacific Clinical Nutrition Market: Tube Feeding, 2015-2026, $ mn	54
Figure 25. Asia Pacific Clinical Nutrition Market: Parenteral Administration, 2015-2026, $ mn	55
Figure 26. Asia Pacific Clinical Nutrition Market: Supplemental Parenteral Nutrition, 2015-2026, $ mn	57
Figure 27. Asia Pacific Clinical Nutrition Market: Total Parenteral Nutrition, 2015-2026, $ mn	58
Figure 28. Asia Pacific Clinical Nutrition Market: All-in-One System, 2015-2026, $ mn	59
Figure 29. Asia Pacific Clinical Nutrition Market: Multiple Bottle System, 2015-2026, $ mn	60
Figure 30. Breakdown of Asia Pacific Clinical Nutrition Market by End User, 2019-2026, % of Revenue	61
Figure 31. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%)	62
Figure 32. Asia Pacific Clinical Nutrition Market: Infant, 2015-2026, $ mn	63
Figure 33. Asia Pacific Clinical Nutrition Market: Children, 2015-2026, $ mn	64
Figure 34. Asia Pacific Clinical Nutrition Market: Adult, 2015-2026, $ mn	65
Figure 35. Asia Pacific Clinical Nutrition Market: Geriatrics, 2015-2026, $ mn	66
Figure 36. Breakdown of Asia Pacific Clinical Nutrition Market by Therapeutic Area, 2019-2026, % of Revenue	68
Figure 37. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%)	68
Figure 38. Asia Pacific Clinical Nutrition Market: Malnutrition, 2015-2026, $ mn	69
Figure 39. Asia Pacific Clinical Nutrition Market: Metabolic Disorders, 2015-2026, $ mn	70
Figure 40. Asia Pacific Clinical Nutrition Market: Gastrointestinal Disorders, 2015-2026, $ mn	71
Figure 41. Asia Pacific Clinical Nutrition Market: Cancer, 2015-2026, $ mn	72
Figure 42. Asia Pacific Clinical Nutrition Market: Neurology, 2015-2026, $ mn	73
Figure 43. Asia Pacific Clinical Nutrition Market: Renal Diseases, 2015-2026, $ mn	74
Figure 44. Asia Pacific Clinical Nutrition Market: Respiratory Diseases, 2015-2026, $ mn	75
Figure 45. Asia Pacific Clinical Nutrition Market: Other Therapeutic Areas, 2015-2026, $ mn	76
Figure 46. Breakdown of Asia Pacific Clinical Nutrition Market by Healthcare Setting, 2019-2026, % of Revenue	78
Figure 47. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Healthcare Setting, Value ($ mn) and Share (%)	78
Figure 48. Asia Pacific Clinical Nutrition Market: Hospitals, 2015-2026, $ mn	79
Figure 49. Asia Pacific Clinical Nutrition Market: Long-term Care Facilities (LTC), 2015-2026, $ mn	80
Figure 50. Asia Pacific Clinical Nutrition Market: Homecare, 2015-2026, $ mn	81
Figure 51. Asia Pacific Clinical Nutrition Market: Inpatient Rehabilitation Facilities, 2015-2026, $ mn	82
Figure 52. Asia Pacific Clinical Nutrition Market: Other Healthcare Settings, 2015-2026, $ mn	83
Figure 53. Breakdown of Asia Pacific Clinical Nutrition Market by Distribution Channel, 2019-2026, % of Revenue	85
Figure 54. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%)	85
Figure 55. Asia Pacific Clinical Nutrition Market: Institutional Sales, 2015-2026, $ mn	86
Figure 56. Asia Pacific Clinical Nutrition Market: Supermarkets & Hypermarkets, 2015-2026, $ mn	87
Figure 57. Asia Pacific Clinical Nutrition Market: Pharmacies, 2015-2026, $ mn	88
Figure 58. Asia Pacific Clinical Nutrition Market: Drug Stores, 2015-2026, $ mn	89
Figure 59. Asia Pacific Clinical Nutrition Market: Online Channels, 2015-2026, $ mn	90
Figure 60. Asia Pacific Clinical Nutrition Market: Other Distribution Channels, 2015-2026, $ mn	91
Figure 61. Breakdown of APAC Clinical Nutrition Market by Country, 2019 and 2026, % of Revenue	93
Figure 62. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	94
Figure 63.  Clinical Nutrition Market in China, 2015-2026, $ mn	95
Figure 64.  Clinical Nutrition Market in Japan, 2015-2026, $ mn	98
Figure 65.  Clinical Nutrition Market in India, 2015-2026, $ mn	100
Figure 66.  Clinical Nutrition Market in Australia, 2015-2026, $ mn	102
Figure 67.  Clinical Nutrition Market in South Korea, 2015-2026, $ mn	104
Figure 68.  Clinical Nutrition Market in Rest of APAC, 2015-2026, $ mn	106
Figure 69. Growth Stage of Asia Pacific Clinical Nutrition Industry over the Forecast Period	108

Key Players (this may not be a complete list and extra companies can be added upon request): 
Abbott Nutrition	
B Braun Melsungen Ag	
BASF SE	
Baxter International Inc.	
Claris Lifesciences Ltd.	
Fresenius Kabi Ag	
Lonza Group AG	
Nestle Health Science	
Nutricia Ltd	
Perrigo Company Plc